GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
1-Year Return
66.36%
This Quarter Return
+17.45%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.17B
AUM Growth
+$356M
(+20%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
5.58%
Top 10 Holdings %
Top 10 Hldgs %
32.24%
Holding
194
New
14
Increased
88
Reduced
77
Closed
13
Top Buys
| 1 |
Chegg
CHGG
|
$53.2M |
| 2 |
eHealth
EHTH
|
$27.7M |
| 3 |
Enphase Energy
ENPH
|
$22M |
| 4 |
Sprout Social
SPT
|
$21.7M |
| 5 |
Zscaler
ZS
|
$12.8M |
Top Sells
| 1 |
CARB
Carbonite Inc
CARB
|
$18.1M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
$17M |
| 3 |
MDCO
Medicines Co
MDCO
|
$14.1M |
| 4 |
Etsy
ETSY
|
$14M |
| 5 |
Teladoc Health
TDOC
|
$12.4M |
Sector Composition
| 1 | Technology | 34.59% |
| 2 | Healthcare | 20.01% |
| 3 | Industrials | 12.27% |
| 4 | Consumer Discretionary | 8.61% |
| 5 | Consumer Staples | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Liquidity Services
LQDT
$837M
| $2.62M | 0.12% |
438,772
+109,349
| +33% | +$652K |
|
127
Cytosorbents Corp
CTSO
$59.6M
| $2.61M | 0.12% |
678,618
+13,914
| +2% | +$53.6K |
|
128
PTC
PTC
$25.4B
| $2.58M | 0.12% |
34,439
+1,860
| +6% | +$139K |
|
129
Fennec Pharmaceuticals
FENC
$257M
| $2.5M | 0.12% |
385,880
-70,099
| -15% | -$455K |
|
|
NEWR
130
DELISTED
New Relic, Inc.
NEWR
| $2.5M | 0.11% |
37,969
+9,120
| +32% | +$599K |
|
131
MacroGenics
MGNX
$131M
| $2.46M | 0.11% |
225,951
+1,695
| +0.8% | +$18.4K |
|
132
Globus Medical
GMED
$8.21B
| $2.39M | 0.11% |
40,629
-18,715
| -32% | -$1.1M |
|
133
Standard BioTools
LAB
$493M
| $2.39M | 0.11% |
685,744
+88,865
| +15% | +$309K |
|
|
SOHO
134
Sotherly Hotels
SOHO
$17M
| $2.39M | 0.11% |
351,858
+31,456
| +10% | +$213K |
|
135
Quanterix
QTRX
$205M
| $2.33M | 0.11% |
98,682
+3,770
| +4% | +$89.1K |
|
136
Protolabs
PRLB
$1.19B
| $2.33M | 0.11% |
22,898
+290
| +1% | +$29.4K |
|
137
Silicon Laboratories
SLAB
$4.47B
| $2.25M | 0.1% |
19,372
-1,764
| -8% | -$205K |
|
138
Monolithic Power Systems
MPWR
$40.7B
| $2.19M | 0.1% |
12,302
-2,196
| -15% | -$391K |
|
139
CRISPR Therapeutics
CRSP
$4.8B
| $2.11M | 0.1% |
34,582
| – | – |
|
|
PFIE
140
DELISTED
Profire Energy, Inc
PFIE
| $2.04M | 0.09% |
1,403,731
+160,386
| +13% | +$233K |
|
|
PFPT
141
DELISTED
Proofpoint, Inc.
PFPT
| $2M | 0.09% |
17,446
+594
| +4% | +$68.2K |
|
142
Castle Biosciences
CSTL
$665M
| $1.82M | 0.08% |
+52,863
| New | +$1.82M |
|
143
Akamai
AKAM
$11.2B
| $1.82M | 0.08% |
21,016
+296
| +1% | +$25.6K |
|
144
Cidara Therapeutics
CDTX
$1.63B
| $1.81M | 0.08% |
23,506
+298
| +1% | +$22.9K |
|
145
Clarus
CLAR
$140M
| $1.73M | 0.08% |
128,003
+346
| +0.3% | +$4.67K |
|
|
RDNW
146
RideNow Group, Inc. Class B Common Stock
RDNW
$147M
| $1.72M | 0.08% |
103,877
+134
| +0.1% | +$2.21K |
|
147
Editas Medicine
EDIT
$230M
| $1.64M | 0.08% |
55,345
+328
| +0.6% | +$9.71K |
|
|
ABMD
148
DELISTED
Abiomed Inc
ABMD
| $1.49M | 0.07% |
8,727
-376
| -4% | -$64.2K |
|
149
Spero Therapeutics
SPRO
$120M
| $1.43M | 0.07% |
148,867
+1,324
| +0.9% | +$12.7K |
|
150
Xenon Pharmaceuticals
XENE
$2.97B
| $1.4M | 0.06% |
106,839
+380
| +0.4% | +$4.98K |
|